Latest Revenue Forecast News

Page 4 of 18
EBR Systems has submitted its WiSE wireless cardiac pacing system for Australian regulatory approval, opening a potential second commercial market after the United States. The application has entered a priority review pathway, but neither approval nor an assessment timetable is guaranteed.
Victor Sage
Victor Sage
20 Oct 2026
Codan has set a first-half FY27 NPAT floor of $162 million after delivering record FY26 results, while targeting Communications revenue growth at the upper end of its 30% to 40% range. The company is benefiting from exceptional demand for unmanned systems, although visibility in conflict markets remains limited beyond the near term.
Sophie Babbage
Sophie Babbage
20 Oct 2026
DroneShield has reached A$261 million in FY2026 Committed Revenue, sitting at the midpoint of its existing A$250 million to A$270 million outlook. The counter-drone specialist also has A$29 million committed for FY2027 and A$17 million scheduled for FY2028 and beyond.
Victor Sage
Victor Sage
15 Oct 2026
Aland Equity Group expects its first capital-light property fund to deliver approximately $4.1 million in net returns by 30 June 2027. The forecast combines $3.37 million in management fees with a further $725,000 in investment returns, but remains subject to shareholder approval and successful lot sales.
Eva Park
Eva Park
15 Oct 2026
BKI Investment Company reported a stronger FY2026 and proposed lifting ordinary dividends to 8.00 cents per share in FY2027. The listed investment company also expects first-half ordinary revenue of approximately $38.0 million, while its shares remained at an 11.8% discount to pre-tax net tangible assets at 30 June.
Claire Turing
Claire Turing
13 Oct 2026
PointsBet expects first-half FY27 revenue of approximately $113 million, down 16% from the prior corresponding period, with normalised EBITDA falling to a loss of $6 million to $8 million. The company attributed the setback to stricter Australian compliance measures and adverse betting results, particularly in AFL.
Victor Sage
Victor Sage
13 Oct 2026
PainChek has expanded its Sabra relationship from two initial facilities to 23 US communities across five operators, covering 808 contracted memory care licences. The immediate test is whether those contracts become implemented recurring revenue by the end of 2026.
Victor Sage
Victor Sage
13 Oct 2026
Firebrick Pharma has raised approximately $732,000 from strategic investors, with its Philippines licensing partner investing $631,750 to lift its holding above 10%. The funding will support US retail production, a Singapore product launch and working capital.
Ada Torres
Ada Torres
12 Oct 2026
Titomic has converted a semiconductor manufacturing validation run into full-rate production, with revenue expected to reach approximately EUR 0.9 million in 2027. The company says the program could rise to about EUR 2.0 million in 2028, although customer and contract details remain undisclosed.
Victor Sage
Victor Sage
8 Oct 2026
InFocus is extending its Codexa platform from US sweepstakes gaming into licensed real-money online gambling markets, initially targeting Curaçao and crypto-native operators. Commercial availability is expected in early 2027, but the expansion still depends on product testing, regulatory registration and customer uptake.
Sophie Babbage
Sophie Babbage
8 Oct 2026
ECS Botanics is taking six Australian-grown medicinal cannabis flower products into the UK through Curaleaf Laboratories, with initial supply targeted for November. The two-year deal offers access to UK sell-through but no guaranteed volumes, revenue or minimum purchases.
Victor Sage
Victor Sage
7 Oct 2026
Connexion Mobility has secured an exclusive supplier agreement with Hyundai Motor America to design, develop and manage a connected car-powered dealer lot platform across the United States. The strategic win adds a major OEM relationship, but its financial value and dealer uptake remain undisclosed.
Victor Sage
Victor Sage
7 Oct 2026

Browse the archive

Full archive